Skip to Main Content U.S. Department of Energy
Economic Development Office


CANCELLED - TREN EVENT: How Life Science Will Heal, Feed & Fuel the World

Friday, September 30, 2011
7:15 AM to 8:30 AM
Add to Calendar



The Three Rivers Entrepreneur Network presents its September seminar: How Life Science Will Heal, Feed & Fuel the World.

Life science is changing how we live. Come hear how Washington State has emerged as a national and global leader in life science. Learn how our state's economy is benefiting from this sector, and how companies and research in the Tri-Cities are contributing. The Washington Biotechnology & Biomedical Association (WBBA) is working diligently to help grow this vital sector and will provide an overview of innovations in Washington's life science industry.

What you'll learn:

  • Why and how Washington is a global life science leader
  • Economic impact of life science in our state
  • WBBA's focus and efforts to support continued life science growth

Who should attend?

  • Business owners
  • Entrepreneurs
  • Investors
  • Marketing professionals


The September TREN event has been cancelled. 

For More Information:

(509) 375-2068

About the Speaker

Chris E. Rivera joined the Washington Biotechnology & Biomedical Association (WBBA) as President in 2009, bringing more than two decades of commercial, licensing, and general management experience in the biopharmaceutical industry. Rivera is dedicated to seeing the life science industry thrive while creating new jobs and companies. Rivera was the founder and CEO of Hyperion Therapeutics, a specialty biopharmaceutical company focused in the development and commercialization of therapies for gastroenterology and hepatology diseases. Prior to starting Hyperion, he was senior vice president of commercial operations at Tercica, Inc., where he was responsible for developing and overseeing Tercica's global commercialization strategies, and was intimately involved in the development and consummation of an international cross-licensing collaboration with Ipsen. As senior vice president of Genzyme Therapeutics, Rivera was largely responsible for building the company's U.S. renal division and assisted in the launch of Renagel® (sevelamer hydrochloride) globally. Earlier in his career, he helped build the initial commercial organizations at Centocor and Cephalon. A Washington State resident since 1985, Rivera holds a Master of Science degree in Audiology from the University of Oklahoma Health Sciences Center; a Bachelor of Science degree in Business from Northwestern Oklahoma State University; and studied Marketing and Management at the Albers Graduate School of Business and Economics at Seattle University.

Register for this event here!


News & Events

Programs & Resources

What's New


Latest News